Advertisement

  • News
  • Columns
  • Interviews
  • BW Communities
  • Events
  • BW TV
  • Subscribe to Print
  • Editorial Calendar 19-20

Latest Articles in BioNTech

Pfizer, BioNTech to submit to FDA for emergency use authorisation for their COVID-19 vaccine candidate

Pfizer, BioNTech to submit to FDA for emergency use authorisation for their COVID-19 vaccine candidate

Read More

EU Could Pay Over $10 Billion For Pfizer And Curevac Vaccines

The EU has separately agreed to pay 10 euros ($11.84) per dose for an initial supply of 225 million doses of the vaccine candidate from CureVac, a discount from the 12 euros the company set as the price for the shot, the official said.

Read More

Pfizer, BioNTech offer Brazil COVID-19 vaccination plan for 2021

Pfizer, BioNTech offer Brazil COVID-19 vaccination plan for 2021

Read More

Pfizer, BioNTech Conclude Phase 3 Study Of COVID-19 Vaccine Candidate, Say It's 95% Effective

The major announcement comes just two days after leading biotechnology company Moderna said on Monday its virus vaccine had an efficacy rate of 94.5 per cent

Read More

Pfizer says Covid-19 vaccine trial complete, cites shot is 95 per cent effective

Pfizer says Covid-19 vaccine trial complete, cites shot is 95 per cent effective

Read More

Spain Authorises Phase III Trial Of Johnson & Johnson COVID-19 Vaccine

The Phase III trial of the two-dose vaccination will be carried out in nine hospitals throughout Spain on volunteers both with and without previous health conditions

Read More

S&P 500 Hits All-Time Closing High After Earnings, Oil Drops On Pandemic Worry

The Dow Jones Industrial Average rose 399.64 points, or 1.37%, to 29,479.81, the S&P 500 gained 48.14 points, or 1.36%, to 3,585.15 and the Nasdaq Composite added 119.70 points, or 1.02%, to 11,829.29.

Read More

BioNTech says no infomation on vaccination start in Germany

BioNTech says no infomation on vaccination start in Germany

Read More

Nasdaq Retreats As Technology Stocks Lose Favor

The Dow Jones Industrial Average rose 262.95 points, or 0.9%, to 29,420.92, the S&P 500 lost 4.97 points, or 0.14%, to 3,545.53 and the Nasdaq Composite dropped 159.93 points to 11,553.86.

Read More

Oil Gains Nearly 3% On Vaccine Hopes, Even As Nations Reimpose Lockdowns

Brent crude futures settled up $1.21, or 2.9%, at $43.61 per barrel. U.S. West Texas Intermediate (WTI) crude futures gained $1.07, or 2.7%, to $41.36.

Read More

Pfizer Vaccine Trial Success Signals Breakthrough In Pandemic Battle

Shares of other vaccine developers in the final stage of testing also rose with Johnson & Johnson up nearly 4% and Moderna Inc, whose vaccine uses a similar technology as the Pfizer shot, up more than 8%.

Read More

Australia signs COVID-19 vaccine deals with Novavax, Pfizer

Australia signs COVID-19 vaccine deals with Novavax, Pfizer

Read More

Australia Signs Two More COVID-19 Vaccine Deals

The Pfizer-BioNTech vaccine along with AstraZeneca's and Novavax's are among the leading candidates in the race to be the first to get regulatory approval in the United States and Europe.

Read More

China's Fosun To Seek Approval For Biontech's COVID-19 Second Vaccine, Ends Trials On First

Fosun is licensed to exclusively develop and commercialize COVID-19 vaccine products developed by using BioNTech's mRNA technology in mainland China, Hong Kong, Macau and Taiwan.

Read More

Dow Advances, S&P Ekes Out Gain As Vaccine Timeline Comes Into Focus

The Dow Jones Industrial Average rose 112.11 points, or 0.39%, to 28,606.31, the S&P 500 gained 0.47 points, or 0.01%, to 3,483.81 and the Nasdaq Composite dropped 42.32 points, or 0.36%, to 11,671.56.

Read More